All‐cause mortality · adults in sinus rhythm after cardioversion of atrial fibrillation
It is very uncertain whether propafenone changes all‐cause mortality compared with placebo or no treatment (very low certainty).
1 finding from 1 review
Withdrawals due to adverse events · adults in sinus rhythm after cardioversion of atrial fibrillation
Propafenone probably leads to higher withdrawals due to adverse effects compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
Proarrhythmia · adults in sinus rhythm after cardioversion of atrial fibrillation
It is very uncertain whether propafenone changes proarrhythmia compared with placebo or no treatment (very low certainty).
1 finding from 1 review
Stroke · adults in sinus rhythm after cardioversion of atrial fibrillation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Recurrence of atrial fibrillation · adults in sinus rhythm after cardioversion of atrial fibrillation
Propafenone probably leads to lower recurrence of atrial fibrillation compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
All‐cause mortality · patients with myocardial infarction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cardiac mortality · patients with myocardial infarction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Overall survival at 30 days after myocardial infarction · patients with myocardial infarction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Ventricular fibrillation · patients with myocardial infarction
It is very uncertain whether lidocaine changes ventricular fibrillation compared with propafenone (very low certainty).
1 finding from 1 review
Adverse events (AEs; adverse drug reaction): heart failure · patients with myocardial infarction
It is very uncertain whether lidocaine changes adverse events (AEs; adverse drug reaction): heart failure compared with propafenone (very low certainty).
1 finding from 1 review
Adverse events (AEs; adverse drug reaction): bilateral bundle branch block · patients with myocardial infarction
It is very uncertain whether lidocaine changes adverse events (AEs; adverse drug reaction): bilateral bundle branch… compared with propafenone (very low certainty).
1 finding from 1 review
Neuropsychiatric adverse event · patients with myocardial infarction
It is very uncertain whether lidocaine changes adverse events (AEs; adverse drug reaction): neuropsychiatric… compared with propafenone (very low certainty).
1 finding from 1 review